Infusion af PBPC accelererer hæmatopoietisk bedring med reduktion af varigheden for risiko for hæmoragiske komplikationer og behov for trombocyttransfusion.
Infusion of PBPCs accelerates haematopoietic recovery reducing the duration of risk for haemorrhagic complications and the need for platelet transfusions.